Spark is a Pharma regulatory consulting firm. We offer a wide range of services in the areas of regulatory affairs and pharmaceutical product development for small to medium size pharmaceutical companies to help them to overcome the challenges within the rapidly evolving global pharmaceutical market.
Spark Pharma regulatory consultants strive to develop long-term relationships with clients, based on the highest levels of integrity, professionalism and trust. We are committed to doing business in an ethical and socially responsible manner.
"As full service Regulatory Affairs Consultancy to the pharmaceutical industry, our aim is to partner our clients on their journey from research and development to the market and beyond, bringing medicines to market in the shortest possible timeframe, whilst exercising cost containment strategies.
Our focus is commercial, the emphasis being on finding a route to market where development costs are minimized and product potential maximized.
To achieve our mission we need to attract, excite, develop and retain exceptional people who share the company's vision and reflect the company's values."
We are driven by a desire to excel and exceed customer expectations, provide a joyous working environment for our people and empower them to think big and set ambitious goals. We want to achieve all this in an environment that promotes integrity.
Achieving significant business in generic product dossier consultancy with a strong presence in Regulated and semi-regulated market, non-regulated.
Success and Us
Everything and Anything
Spark Pharma Regulatory is managed by a industry trained regulatory professional having invaluable Pharma experience from Reputed pharmaceutical company.
We assist our clients by guiding the product development in line with the country specific requirements, data generation, document compilation for submission to various Regulatory Agencies all over the world.
The registration being the pre-requisite for export to any market, the client gets all round assistance in technical data generation and regulatory strategy to enter new markets. Thus, enhancing their market portfolio and revenues.